1065 related articles for article (PubMed ID: 19084540)
1. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
Mukai Y; Shibata H; Nakamura T; Yoshioka Y; Abe Y; Nomura T; Taniai M; Ohta T; Ikemizu S; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
J Mol Biol; 2009 Jan; 385(4):1221-9. PubMed ID: 19084540
[TBL] [Abstract][Full Text] [Related]
2. Generation of mouse macrophages expressing membrane-bound TNF variants with selectivity for TNFR1 or TNFR2.
Shibata H; Abe Y; Yoshioka Y; Nomura T; Sato M; Kayamuro H; Kawara T; Arita S; Furuya T; Nagano K; Yoshikawa T; Kamada H; Tsunoda S; Tsutsumi Y
Cytokine; 2010 Apr; 50(1):75-83. PubMed ID: 20045350
[TBL] [Abstract][Full Text] [Related]
3. Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning.
Abe Y; Yoshikawa T; Inoue M; Nomura T; Furuya T; Yamashita T; Nagano K; Nabeshi H; Yoshioka Y; Mukai Y; Nakagawa S; Kamada H; Tsutsumi Y; Tsunoda S
Biomaterials; 2011 Aug; 32(23):5498-504. PubMed ID: 21546081
[TBL] [Abstract][Full Text] [Related]
4. Novel protein engineering strategy for creating highly receptor-selective mutant TNFs.
Nomura T; Abe Y; Kamada H; Inoue M; Kawara T; Arita S; Furuya T; Yoshioka Y; Shibata H; Kayamuro H; Yamashita T; Nagano K; Yoshikawa T; Mukai Y; Nakagawa S; Taniai M; Ohta T; Tsunoda S; Tsutsumi Y
Biochem Biophys Res Commun; 2009 Oct; 388(4):667-71. PubMed ID: 19682974
[TBL] [Abstract][Full Text] [Related]
5. Creation of lysine-deficient mutant lymphotoxin-alpha with receptor selectivity by using a phage display system.
Yoshioka Y; Watanabe H; Morishige T; Yao X; Ikemizu S; Nagao C; Ahmad S; Mizuguchi K; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
Biomaterials; 2010 Mar; 31(7):1935-43. PubMed ID: 19853911
[TBL] [Abstract][Full Text] [Related]
6. Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2.
Boschert V; Krippner-Heidenreich A; Branschädel M; Tepperink J; Aird A; Scheurich P
Cell Signal; 2010 Jul; 22(7):1088-96. PubMed ID: 20206684
[TBL] [Abstract][Full Text] [Related]
7. Creation of an improved mutant TNF with TNFR1-selectivity and antagonistic activity by phage display technology.
Nomura T; Abe Y; Kamada H; Inoue M; Kawara T; Arita S; Furuya T; Minowa K; Yoshioka Y; Shibata H; Kayamuro H; Yamashita T; Nagano K; Yoshikawa T; Mukai Y; Nakagawa S; Tsunoda S; Tsutsumi Y
Pharmazie; 2010 Feb; 65(2):93-6. PubMed ID: 20225650
[TBL] [Abstract][Full Text] [Related]
8. Fast binding kinetics and conserved 3D structure underlie the antagonistic activity of mutant TNF: useful information for designing artificial proteo-antagonists.
Mukai Y; Nakamura T; Yoshioka Y; Shibata H; Abe Y; Nomura T; Taniai M; Ohta T; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
J Biochem; 2009 Aug; 146(2):167-72. PubMed ID: 19386778
[TBL] [Abstract][Full Text] [Related]
9. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
Qin W; Feng J; Li Y; Lin Z; Shen B
Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
[TBL] [Abstract][Full Text] [Related]
10. Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro.
Schäfers M; Sommer C; Geis C; Hagenacker T; Vandenabeele P; Sorkin LS
Neuroscience; 2008 Nov; 157(2):414-23. PubMed ID: 18838115
[TBL] [Abstract][Full Text] [Related]
11. A conformation-constrained peptide library based on insect defensin A.
Zhao A; Xue Y; Zhang J; Gao B; Feng J; Mao C; Zheng L; Liu N; Wang F; Wang H
Peptides; 2004 Apr; 25(4):629-35. PubMed ID: 15165719
[TBL] [Abstract][Full Text] [Related]
12. Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activity.
Abe Y; Yoshikawa T; Kamada H; Shibata H; Nomura T; Minowa K; Kayamuro H; Katayama K; Miyoshi H; Mukai Y; Yoshioka Y; Nakagawa S; Tsunoda S; Tsutsumi Y
J Immunol Methods; 2008 Jun; 335(1-2):71-8. PubMed ID: 18417150
[TBL] [Abstract][Full Text] [Related]
13. Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1.
Tada Y; Ho A; Koarada S; Morito F; Ushiyama O; Suzuki N; Kikuchi Y; Ohta A; Mak TW; Nagasawa K
Clin Immunol; 2001 Jun; 99(3):325-33. PubMed ID: 11358427
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.
Higuchi Y; McTiernan CF; Frye CB; McGowan BS; Chan TO; Feldman AM
Circulation; 2004 Apr; 109(15):1892-7. PubMed ID: 15051641
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha and its receptors contribute to apoptosis of oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy) sustaining chronic mechanical compression.
Inukai T; Uchida K; Nakajima H; Yayama T; Kobayashi S; Mwaka ES; Guerrero AR; Baba H
Spine (Phila Pa 1976); 2009 Dec; 34(26):2848-57. PubMed ID: 19949368
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of tumor necrosis factor receptors 1 and 2 of the goldfish (Carassius aurutus L.).
Grayfer L; Belosevic M
Mol Immunol; 2009 Jul; 46(11-12):2190-9. PubMed ID: 19446337
[TBL] [Abstract][Full Text] [Related]
17. Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window.
Shibata H; Yoshioka Y; Ikemizu S; Kobayashi K; Yamamoto Y; Mukai Y; Okamoto T; Taniai M; Kawamura M; Abe Y; Nakagawa S; Hayakawa T; Nagata S; Yamagata Y; Mayumi T; Kamada H; Tsutsumi Y
Clin Cancer Res; 2004 Dec; 10(24):8293-300. PubMed ID: 15623605
[TBL] [Abstract][Full Text] [Related]
18. Mutants of lymphotoxin-α with augmented cytotoxic activity via TNFR1 for use in cancer therapy.
Morishige T; Yoshioka Y; Narimatsu S; Ikemizu S; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
Cytokine; 2013 Feb; 61(2):578-84. PubMed ID: 23246116
[TBL] [Abstract][Full Text] [Related]
19. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.
Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K
J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365
[TBL] [Abstract][Full Text] [Related]
20. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.
Arnott CH; Scott KA; Moore RJ; Robinson SC; Thompson RG; Balkwill FR
Oncogene; 2004 Mar; 23(10):1902-10. PubMed ID: 14661063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
